Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Massively parallel sequencing for the detection of adventitious viruses.

Kolman JL.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):663-7. doi: 10.5731/pdajpst.2011.00836. Review.

PMID:
22294594
2.

Introduction to workshop: adventitious viruses in biologics--detection and mitigation strategies.

Khan AS, Hughes P, Wiebe M.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):544-6. doi: 10.5731/pdajpst.2011.00817.

PMID:
22294575
3.

Overview of emerging technologies to detect adventitious agents.

Onions D.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):654-9. doi: 10.5731/pdajpst.2011.00834. Review.

PMID:
22294592
4.

Current European regulations for control of adventitious virus safety.

Bl├╝mel J.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):568-79. doi: 10.5731/pdajpst.2011.00821.

PMID:
22294579
5.

Current testing methods and challenges for detection of adventitious viruses.

Khan AS.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):627-33. doi: 10.5731/pdajpst.2011.00831.

PMID:
22294589
6.

Application of quality by design in the control of adventitious viruses: gaps in current processes in the prevention of virus contaminants.

Cherney B.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):754-66. doi: 10.5731/pdajpst.2011.00849.

PMID:
22294609
7.

A microarray platform for virus detection and identification.

Munroe D.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):691. doi: 10.5731/pdajpst.2011.00839.

PMID:
22294600
8.

FDA post-approval expectations for adventitious virus contamination prevention.

Friedman RL.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):698-712. doi: 10.5731/pdajpst.2011.00846.

PMID:
22294604
9.

Viral Safety of Plasma-derived Products.

Farshid M.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):737-53. doi: 10.5731/pdajpst.2011.00848.

PMID:
22294608
10.

Summary of breakout session e.

Brorson K, Lubiniecki A.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):616-9. doi: 10.5731/pdajpst.2011.00828.

PMID:
22294586
11.

Summary of Breakout Session B: Regulatory Expectations for CGMP.

Sausville R, Cazeault C.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):713-4. doi: 10.5731/pdajpst.2011.00847.

PMID:
22294605
12.

Breakout Session A: Elimination or Treatment of High-risk Raw Materials.

Kiss R, Drews R.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):767-77. doi: 10.5731/pdajpst.2011.00850.

PMID:
22294610
13.

Use of DOP-PCR in Non-Specific Virus Detection.

Uhlenhaut C, McClenahan S, Krause PR.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):681-4. doi: 10.5731/pdajpst.2011.00842.

PMID:
22294597
14.

Identification and remediation of a cell culture virus contamination.

Jones N.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):615. doi: 10.5731/pdajpst.2011.00822.

PMID:
22294585
15.

Summary of breakout session f: facility and equipment decontamination strategies.

Norwood LP, Suvarna K.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):625-6. doi: 10.5731/pdajpst.2011.00829.

PMID:
22294588
16.

PDA Cell Substrate Task Force: Emerging Technologies for Virus Detection Technical Document--A Progress Report.

King K, Wiebe M.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):693. doi: 10.5731/pdajpst.2011.00844.

PMID:
22294602
17.

Case study of apparent virus contamination in biopharmaceutical product at centocor.

Hendricks LC, Vacante DA.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):612-3. doi: 10.5731/pdajpst.2011.00825.

PMID:
22294583
18.

Regulatory approaches for control of viral contamination of vaccines.

McClenahan S, Uhlenhaut C, Krause PR.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):557-62. doi: 10.5731/pdajpst.2011.00819.

PMID:
22294577
19.

Breakout session C summary: current virus detection methods.

Byrnes AP, Willkommen H.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):660-2. doi: 10.5731/pdajpst.2011.00835.

PMID:
22294593
20.

Nanostring's nCounter--A True Digital Target Profiling Technology.

Morrow M, Donaldson J.

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):692. doi: 10.5731/pdajpst.2011.00841.

PMID:
22294601

Supplemental Content

Support Center